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INTRODUCTION
Migraine affects as many as 18% of women and 6% of
men aged 25-55 years and is under-recognized
worldwide.1 Although majority of the cases are idiopathic,
sometimes migraine can also present as a symptom of
another underlying pathology or disorder that perturbs the
migraine-generating structures, causing secondary
migraine headaches. Diagnosis of symptomatic migraine
can be made when headaches which sat isfy the
International Headache Society (IHS) diagnostic criteria
for migraine occur due to an underlying pathology and
cannot be classified as “idiopathic”. We report the causes
of symptomatic migraine based on a critical literature
review. Symptoms specific to a particular organic disorder
are often present but migraine can sometimes be the
only clinical manifestation. 
Knowledge of these entities will alert the astute clinician
to investigate the possibility of an underlying disorder.
This may require neuroimaging, genetic testing and often
multi-disciplinary input from, for example, vascular
surgeons, cardiologists or oncologists. 
METHODS
“Symptomatic migraine” is a migraine secondary to an
underlying cause and cannot be classified as idiopathic.
Our objective was to find causes of “symptomatic
migraine” and hence to include the diseases that can
present with migraine or where migraine is a prominent
associated feature, and diseases where diagnosis of
underlying potential etiology can make a difference to the
management of migraine or modify the choice of anti-
migraine treatment. We performed a detailed librarian
assisted Pub Med Boolean search covering articles from
Premed-line to March 29, 2007. Entering the keywords
“symptomatic migraine” gave us 380 articles from which
we initially selected 162 articles including case reports,
whose subject matter was relevant to symptomatic
migraine or which described diseases that presented with
migraine like symptoms. Articles which dealt only with
management of migraine were excluded. 
From these search results, we selected 147 relevant
articles.  The references of these articles were also
reviewed and where indicated they were also retrieved. In
total we reviewed 164 articles. These articles described
diseases which presented with migraine, had migraine as
a major feature, or occurred in concurrence with migraine
due to another common underlying pathology. We
excluded articles in which migraine was described as a
primary disorder and those that dealt with management
and complications of migraine.  Within each identified
subsection, relevant section references were searched
and selected as well. We sorted the international library
(ILL) when the full text article was not available on
PubMed. All articles were reviewed between the three
authors and points were clarified by mutual discussion.
This was to ensure that the review would involve only the
predefined characteristics. 
We based our classification of symptomatic migraine on
the ICHD-II classification for secondary headaches:  
1. Head and neck trauma
2. Vascular disorders
a. Intracranial
b. Extracranial
3. Intracranial non vascular disorders
4. Substance abuse or withdrawal
5. Infection
6. Disorders of homeostasis
7. Disorders of the cranium, eyes, ears, nose, 
sinuses, teeth, mouth or other cranial or facial 
structures
8. Psychiatric disorders
9. Cardiac abnormalities
10. Metabolic disorders
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REVIEW
As the pathogenesis of migraine begins to be better
understood, it appears that disorders that perturb the
structures that are involved in generating spontaneous
migraine can cause “symptomatic migraine”.
1. Head/neck trauma
Minor head and neck trauma and whiplash injuries can
be followed by severe chronic headaches, which may
present as classic migraines. Headaches may begin
immediately or within the first few days after injury and
may respond wel l  to prophylact ic ant i-migraine
treatment.2
Juvenile head trauma syndromes resemble classic
migraine.3 Juveni le head trauma syndromes are
characterized by four types of attacks; 1) hemiparesis, 2)
somnolence, irritability, and vomiting, 3) blindness and 4)
brain stem signs, which make the clinical presentation
similar to migraine.3 Migraine due to juvenile head
trauma and contact sports is usually the result of a minor
injury and is not associated with amnesia.4 Head injury is
followed by a symptom free interval that lasts for several
minutes, followed by motor, visual, sensory or brainstem
symptoms. These symptoms last for 15 to 20 minutes
and are fol lowed by headache, with nausea and
vomiting.4 There are no signif icant differences in
treatment, however as far as a history of trauma is
concerned it is prudent to rule out other associated
injuries - which may not be reported in the juvenile cases
2.   Vascular Disorders  
a. Intracranial vasculopathy    
i. Ischemic Small Vessel Disease: CADASIL  (Cerebral
Autosomal Dominant  
Arteriopathy with Subcortical Infarcts and
Leukoencephalopathy)
Due to the high prevalence of primary migraine, CADASIL
is often overlooked as a potential cause and may
therefore not be diagnosed until the first stroke occurs, a
symptom more commonly associated with CADASIL.5-8
CADASIL is an autosomal dominant disorder whose gene,
Notch3, located on chromosome 19, encodes a 300-kd
transmembrane protein with a receptor and cell signal
transduction function. A typical arteriopathy with electron
dense granular depositions in the media of small cerebral
arteries underlies this disorder. These arterial lesions can
be found, to a lesser extent, in extra-cerebral arteries
such as skin arterioles.9 As the disease becomes better
understood, migraine with aura is proving to be a
common early manifestation of CADASIL patients,
reported in 38% to 60% of affected individuals about 15
years before the first stroke.10-12
The natural course of CADASIL starts with migraine with
aura in the 30s, subcort ical strokes at age 45,
accompanied psychiatric abnormalities and dementia in
the 60-70s.13,14 The aura is prolonged, usual ly
hemiplegic, visual, sensory, aphasic  and often with
“basilar” type features.15 Retinal migraine has also been
reported.16 Migraine coma is reported as a complication
of CADASIL. This is a reversible acute encephalopathy
(lasting 7 -14 days) sometimes associated with fits.17
The head MRI in the younger (<35 years ) migraineurs
shows confluent white matter hyperintensities in T2
weighted and flair images in the anterior temporal lobes,
the frontal lobes, and the per iventr icular f rontal
caps.14,18 In more advanced cases, the external capsule
may be involved.19 Regardless of the type of migraine
phenotype, abnormal MRI is invariably seen.20 These
younger patients may not have associated dementia,
although neuropsychiatric testing may show a frontal lobe
type cognitive disorder.21 Opthalmologic examination may
show generalized arterial narrowing and arteriovenous
nicking but only minimal functional disturbance.22 The
transcranial doppler (TCD) shows reduced intracranial
velocities.23 In addition, CADASIL has been reported in
patients with normal brain MRI; these patients  have
abnormal skin biopsies.24 Aura and migraine in CADASIL
may respond to acetazolamide.25,26
ii.     Cerebroretinal Small Vessel Syndromes
Cerebral small vessel disease is responsible for about
20% of all strokes and characteristically small vessel
strokes are not associated with headaches. However, the
cerebroretinal small vessel syndromes are a group of
disorders associated with retinal vascular abnormalities,
small vessel ischemia, leukoencephalopathy and frequent
migraine with aura. 
The main hereditary vascular conditions involving both
retinal and cerebral vessels include cerebroretinal
vasculopathy, HERNS (hereditary endotheliopathy with
retinopathy, nephropathy, and stroke), and hereditary
vascular retinopathy; all of which are linked to the same
locus on chromosome 3p21.27 A novel hereditary
autosomal dominant condition affecting both retinal and
cerebral vessels has been described as characterized by
infanti le hemiparesis, migraine with aura, retinal
hemorrhage, ret inal arter ia l  tortuosity,  and
leukoencephalopathy with dilatation of perivascular
spaces and microbleeds on brain MRI.28 Patients with
headache that is migrainous with aura and cerebral small
vessel disease should receive a gradient echo MRI and
ret inal f lourescein angiogram to diagnose these
disorders. Table 1 summarizes disorders of the small
blood vessels of the brain.
iv.   Amyloid angiopathy
Cerebral amyloid angiopathy is a disorder affecting the
elderly, and usually presents as a non hypertensive
intracerebral hemorrhage in a lobar location. A peculiar
pattern of its presentation is continuous spread of
symptoms. It is important to investigate elderly patients
complaining of typical “aura” sans migraine. These auras
may be the clinical correlates of petechial hemorrhages
induced by the deposition of amyloid in fragile vessels.29
Although there is no cure, str ict avoidance of
antiplatelets, anticoagulants, Gingko and all agents that
prolong the bleeding time is advocated. The diagnosis of
probable amyloid angiopathy may be made with a
gradient echo MRI in vivo.30
Hereditary amyloidosis is a group of genet ical ly
heterogeneous autosomal-dominant inherited disorders
characterized by the ubiquitous extracellular deposit of
fibrillary aggregated proteins. In the vast majority of
cases, the offending protein is variant transthyretin (TTR),
of which over 80 mutations are known.31 TTR amyloidosis
presents with polyneuropathy occasionally accompanied
by vitreous amyloid opacities. Rarely, involvement of the
leptomeningeal or meningovascular structures dominates
the clinical picture.32 A marked delay in perfusion time
and an enlargement of arterioles are found via cerebral
angiography, suggesting a disturbed autoregulation of
cerebral blood vessels by the amyloid-laden vasculature,
which may lead to hemodynamic changes.33
Arter iography often precipitates prolonged
encephalopathy. This altered hemodynamic mechanism
results in small areas of cortical ischemic changes, which
may then cause fluctuating consciousness, TIA and
migraine aura like symptoms.34 Diagnosis may be made
by postcontrast T1-weighted imaging which shows
smooth leptomeningeal enhancement. Also noted on
gradient echo sequences are a few punctate areas due to
hemosiderin deposition.33 Although orthoptic liver
transplantat ion is a cure in Famil ia l  Amyloid
Polyneuropathy (FAP), its effectiveness in those with CNS
manifestations is not known.35
b. Extracranial Vasculopathy 
Large Vessel Vasculopathies: 
i. Carotid Artery  and Vertebral artery dissection
Spontaneous carotid artery dissection may present with
aura and headache indistinguishable from migraine and
are more common in migraineurs.36,37 Headache and
neck pain may be the only symptoms of spontaneous
carotid artery dissection.38 Marching impairments from
one modality to another, scintillating scotoma,39 aphasia
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TABLE 1. Hereditary disorders affecting small blood vessel of the brain
Disorder Leuko- Lacunar Other Retinal arteriolar Skin arteriolar Systemic Migraine
encephalopathy Infarcts findings abnormalities abnormalities
CADASIL ++ ++ - + ++ - ++
HERNS + + Contrast ++ + ++ ++
enhancing 
lesions (++)
HVR + - - ++ - - ++
Hereditary ++ + Dilated     ++ - - ++
infantile perivascular
hemiparesis, spaces (++)
retinal arteriolar unilateral
tortuosity & ventricular
Leuko- enlargement
encephalopathy (+)
CADASIL= cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; HERNS= hereditary endotheliopathy with
retinopathy, neuropathy and stroke; HVR= hereditary vascular retinopathy; * = ultra structural analysis of biopsy material; ++ = prominent sign; 
+ = may be present
Brain MRI
and sensory impairment have been reported.40 Odd
accompaniments l ike pulsatile tinnitus, headache
accompanied by aura, l imb shaking, and Horners
syndrome should raise the suspicion of carot id
dissection.40 Moreover, carotid artery dissection is more
likely to present with migraine with aura, as opposed to
migraine without aura.
Vertebral artery dissection often presents with headache
mimicking a migrainous attack followed by basilar
ischemic symptoms.41 The presenting symptoms are
often characterized by severe occipital headache,
followed by nausea, vomiting and vertigo.42 Migraine
associated with vertebral artery dissection is usually
ipsilateral to the side of the dissection and may also be
associated with neck pain.43 Vertebral artery dissection
appears to be an important consideration in pediatric
atypical migraines associated with new onset neurological
dysfunction.43
c. Vascular Malformations
i. Sturge-Weber Syndrome
The Sturge-Weber syndrome (SWS), also cal led
encephalotrigeminal angiomatosis, is a neurocutaneous
disorder with angiomas involving the leptomeninges and
skin of the face (port-wine stain). Patients may present
with cortical, often occipital, calcifications and cranial
angiomatosis without the cutaneous port wine stain.44 All
patients may not manifest the common symptoms of
epilepsy and cognit ive retardation but, may have
hemiplegic migraines.45 In a specific study of headaches
in SWS, migraine headache occurred in 28%, and
neurologic deficits occurred in 58% of patients during the
migraine.46 The prevalence of migraine in children
younger than 10 years was 31% in children with SWS,
much greater than the 5% prevalence in the general
population.46 In a single report, the migraine aura
resolved with aspirin.47 In another case celiac disease
with folic acid deficiency was found to be the cause of
the occipital calcifications.48
ii.   Intracranial arteriovenous malformations (Occipital 
AVM)
Occipital AVM may occasionally be confused with
migraine.49 A report descr ibes a pat ient whose
“symptomatic migraine” fulfilled IHS criteria for migraine,
and resolved after resolution of the AVM.50 Clinically
distinguishing characteristics include late onset, fixed
laterality, cranial bruit,51 concomitant “flashes” or
occipital epilepsy like phenomena and crash migraine
with homonymous hemianopsia.52-54
iii. Pontine cavernoma 
Studies have shown that the periacqueductal gray, locus
ceruleus and the nucleus raphe are the antinociceptive
structures of the brainstem whose dysfunction could
disinhibit the trigeminal system and lead to a migraine
attack. Dorsal pontine activation, has been demonstrated
in human PET studies of migraine.55 Unilateral migraine
can be associated with a pontine cavernoma affecting the
contralateral nucleus raphe magnus, with subsequent
loss of laterality over time as a result of local spread from
microhemorhhages. Thus cavernous malformations of
these “migraine generator areas” can act as irritant foci
for migraine activation.56,57 
iv.      Intracranial aneurysms
Migraine may be associated with a higher incidence of
dissections and dissecting aneurysms of the posterior
circulation in particular.58 Sumatriptan may induce
clinical relief in real SAH when misdiagnosed and treated
as migraine.59
v.      Moyamoya disease  
Moyamoya is a chronic cerebral vascular disease,
characterized by occlusion of the arteries around the
Circle of Willis, with resultant collateral circulation. This
gives rise to a smoky angiographic appearance of the
vascular collaterals and hence the name “moyamoya”,
derived from a Japanese word that means puffy or
obscure.60 The common clinical presentations include
ischemic events, hemorrhagic stroke and epilepsy, and
are more prevalent in children than in adults. The
vascular stenosis seen in the Circle of Willis in moyamoya
disease can impair the posterior circulation. Decreased
occipital perfusion has been suggested as a trigger for
migraine with aura.61 Hence patients with atypical
migraine should be investigated for underlying vascular
diseases including moyamoya.61
d.   Thromboembolic Ischemia (Stroke or TIA)
A bidirectional relationship seems to exists between
stroke and migraine.62 Migraine-stroke are a group of
ent i t ies in which migraine and stroke occur
simultaneously and include migrainous stroke.63 Cerebral
ischemia can induce migraine, and presents primarily as
migraine with aura.64 Moreover, both stroke and migraine
maybe be the result of a third underlying condition, e.g. a
stroke diathesis,63,64 and hence these need to be kept in
mind when diagnosing and investigating migraine as a
consequence of stroke or cerebral ischemia.   
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e.   Plasma Hypercoagubility
A higher frequency of underlying prothrombotic conditions
have been reported in migraine patients.65 Migraine is
one of the clinical manifestations of antiphospholipid
antibody syndrome.66 Patients with SLE and RA may also
present with migraine, and antiphospholipid antibody
levels are raised in these migraniours.67
Ocular migraine, also known as retinal migraine, may
occur in antiphospholipid antibody syndrome. It is
characterized by transient monocular loss of vision
followed by headache.68 Visual symptoms may be the
result of ammorosis fugax, central retinal artery or vein
occlusion, and transient ischemic attacks.69 Important
clues in the history of a patient with migraine, that may
point to antiphospholipid antibody syndrome, or other
prothrombotic states, would be recurrent thrombosis
especially in young patients, recurrent pregnancy losses
or thrombocytopenia.68 An ophthalmologic exam would
be essential in these patients. 
3.   Nonvascular Intracranial Disorders
i. SMART Syndrome (Stroke like migraine attacks 
after radiation therapy) 
This is a rare and probably under diagnosed condition in
those adult pat ients who present with migraines
associated with complex prolonged neurologic deficit, and
a previous history of childhood cranial irradiation for brain
tumour.70 These patients often have brainstem cavernous
malformations; radiation related capillary telangiectasias
and evidence of superficial siderosis on their baseline
MRI. They have headaches, photophobia, v isual
scintillations and neurologic deficits that resolve over a
period ranging from 12 hours to days. Ictal FLAIRE MRI
shows gyral thickening with negative diffusion scans. EEG
demonstrates slowing, and PET shows intense ictal
hypermetabolism that subsequently resolves.70 All
patients reported have shown ongoing pathology in the
brainstem or posterior circulation, probably areas that
trigger the migraine generating mechanisms. 
ii. Lymphocytic Pleocytosis 
Pseudomigraine with pleocytosis is a self-limited and
rather a benign disorder, characterized by recurrent bouts
of migrainous headaches, prolonged aura and
cerebrospinal fluid abnormalities with increased opening
pressure. Patients with this condition are between 15 and
40 years of age. The syndrome is more frequent in men.
These headaches are described as predominantly
throbbing and bilateral with a variable duration (mean of
19 hours). The average duration of the transient
neurologic deficit is 5 hours. Sensory (78% episodes),
aphasic (66%), and motor (56%) disturbances are the
most common associated features. Migraine-like visual
symptoms are relatively rare (18% episodes). Patients are
asymptomatic between episodes and after the
symptomatic period (duration > 3 months). Lymphocytic
pleocytosis (10 to 760 cells mm3) and increased
cerebrospinal fluid protein are found with negative
bacteriologic, viral, fungal, and immunologic studies.71
Syphilis must be ruled out in these patients.72 Brain
computed CT and MRI are normal including DWI,73 but
an electroencephalogram frequently shows focal slowing
over the symptomatic brain area. SPECT reveals transient
focal areas of decreased uptake consistent with the
clinical symptoms.74
iii. Neoplasm   
Intracranial neoplasms, can present with migraine along
with other focal neurologic deficits and signs of increased
intracranial pressure.75 In some cases migraine may be
the only symptom of intracranial neoplasms, and studies
have suggested occipital  lobe tumors, including
meningiomas, as a cause of migraine with aura.75-77
Cases have described occipital lobe tumors to present
with migraine that may be characterized by throbbing
headaches, visual auras, nausea, photophobia and
phonophobia. The migraines may be refractory to medical
management and respond only to surgical removal of the
tumor.75-77
iv. Pineal Cyst  
Pineal cysts are most often seen in women in their third
decade of l i fe, and most commonly present with
headache.78 About half of the headache cases are
migraines, which may either be migraine with aura,
migraine without aura or chronic migraine.79
v. Septum Pellucidum Cyst 
A septum pellucidum cysts lies between the walls of the
lateral ventricles. The walls of the cyst demonstrate
lateral bowing and are more than 10 mm apart.80
Septum pellucidum cysts are found in approximately 15
% of adult brains.81 Asymptomatic cysts may expand,
causing compression of surrounding structures and
producing symptoms. They may cause obstruction of the
interventricular foramen, giving rise to hydrocephalus, or
compress the deep venous structures of the brain, or the
hypothalmoseptal triangle.81 The most common symptom
of septum pellucidum cysts is intermittent headaches,
which include migraine.82
vi. Multiple Sclerosis (MS)
Migraines are a common feature of multiple sclerosis and
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migraine-type vascular headaches may be a presenting
symptom in MS patients.83 Migraines also occur during
MS exacerbations and relapses, and changes in serotonin
function have been proposed as a link between the
migraines and MS exacerbations and relapses.84 It has
been suggested that altered function of the red nucleus,
periaqueductal gray matter and substantia nigra, play a
role in the pathophysiology of migraine and demyelinating
lesions of these regions are seen in MS patients with
migraine.85 Hence presence of midbrain plaques in MS
patients increases the likelihood of migraine type
headaches in these patients.86
vii. Behcets' Disease 
Nervous system involvement is seen in 5 % of the cases
of patients with Behcets' syndrome, headache being the
most common neurological symptom.87 Headaches may
even occur in Behcets' syndrome in the absence of any
other neurological problem.88 Migraine is one of the most
common headaches seen in Behcets ' patients.89
Migraines have a high prevalence of visual or sensory
aura, and result in severe disability in many cases.88
viii. Idiopathic Hypertrophic Cranial Pachymeningitis
Idiopathic hypertrophic cranial pachymeningitis is a
disorder of the dura mater. The pathogenesis is diffuse or
localized thickening of the dura mater. The most frequent
clinical manifestation is a chronic daily headache,
particularly chronic migraine-like headache which is
lateralized to the side of the dural lesions. A gadolinium
enhanced MRI, which will reveal the dural lesions, is
required to rule out the disorder in a patient presenting
with chronic migrainous headaches.90
ix. Epilepsy
Periictal headaches are a feature of parieto-occipital
epilepsy, and may on rare occasion be the presenting
symptom.91,92 The periictal headaches, may be of
migrainous nature and disappear with the treatment of
epilepsy. Parieto-occiptal epilepsy is also characterized by
illusions and visual hallucinations, and needs to be
differentiated from a migraine attack.91
4. CNS Infection
Migraine-like headaches, particularly migraine with aura,
are a frequent manifestation of neurosyphilis, and the
underlying infection needs to be detected to prevent
further complications of the disease.93 A careful
neurological examination along with CSF analysis needs
to be performed in such patients. 
Migraine like headaches have also been described as a
feature of bacterial meningitis, with two cases showing
poor response of these headaches to sumatriptan
management.94 Migraine is also a common manifestation
of acquired CNS Toxoplasma gondi i  infections in
immunocompromised individuals.95
5.   Disorders of Cranium, ENT, Eyes Neck, Sinuses  
and Teeth
i. Schimke immuno-osseos dysplasia
Schimke immuno-osseous dysplasia ( SIOD ) is a rare
autosomal recessive disorder. It is caused by a mutation
in the chromatin remodel ing protein SMARCAL1
(SW/SNF2 related, matrix associated, actin dependent
regulator of chromatin, subfamily a-like 1).96 The disease
results in steroid resistant nephr i t ic syndrome,
spondyloepiphyseal dysplasia, and T-cell deficiency.97
One study has shown that about half the patients with
this disorder complain of severe and disabling migraine
like headaches.107 It is postulated that the migraines
result from vascular, neuroimmune, or neurovascular
defects due to the gene mutation.97
ii. Progressive Hemifacial Atrophy ( Parry Romberg   
Syndrome )
Parry Romberg Syndrome is a disorder of unknown
etiology characterized by gradual wasting of one side of
the face due to loss of subcutaneous tissue. It often
begins in childhood. The disorder may be manifested by
hemiplegic migraines, and one case describes these
migraines to be ipsilateral to the facial wasting.98
6.  Psychiatric disorders
i. Tourette Syndrome
Tourrette syndrome is a common childhood movement
disorder, featured by motor and phonic tics along with
psychiatric abnormalities including obsessive compulsive
disorder. The frequency of migraine headaches in
Tourrette syndrome is almost four times the frequency in
the general population.99,100 This may be explained by
the hypothesis that both conditions are caused by an
underlying pathology in the metabolism of serotonin.100
7.  Cardiac Abnormalities
i. Patent Foramen Ovale (PFO)
The possible relationship between migraine with aura and
paradoxical embolism from PFO was investigated in a
study on 74 patients presenting with acute stroke of
undetermined origin. PFO was found in 44 of 74 patients,
36% of whom had migraine with aura (MA) compared to
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13% MA patients without PFO.101 Of 25 patients in
whom the PFO was considered to play a causal role in the
stroke, 52% had MA whereas only 16% of 19 patients in
whom PFO was considered unrelated had MA. Patients
with MA and PFO, treated either with surgical closure or
anticoagulants, noticed complete disappearance of MA
attacks.101
Closure of interatrial communications may result in
improvement of migraine headaches.102,103 In a recent
study, 42% of patients undergoing percutaneous closure
of an interatr ial communication primari ly for the
secondary prevention of stroke or closure of ASD were
migraineurs. At 3 months after closure of the interatrial
communication, episodes of migraine headache had
ceased in (60%) of these patients. Among the patients
who experienced migraine with aura, 75% had complete
resolution. Those who experienced migraine without aura,
31% had complete resolution. Of the remaining patients,
40% experienced significant improvement in frequency
and severity of migraine headache. The benefit has been
sustained in this population over a median follow-up
period of 18 months.104
It is therefore, imperative to do a thorough neurologic
review in patients presenting with migraine with aura who
also have a cardiac murmur, or have a crochetage
pattern on EKG.105 A possible history of TIA needs to be
ruled out in such patients and a bubble study and
antiplatelet prophylaxis need to be considered.
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Historical Features Suspect Findings
Aura Sans Migraine , age >60 Micorhemmorhage of Cerebral Gradient Echo MRI showing “ dark 
Amyloid Angiopathy spots”
Migraine Precipitated by Long Periods Idiopathic Ketotic Gradient Echo MRI showing  “ dark 
of Fasting Hypoglycemia spots”
Prolonged Aura MELAS , CADASIL , MRI  posterior occipital WMDx (MELAS)
Pseudomigraine with Anterior temporal and External capsule 
lymphocytosis WMD (CADSIL ), MRI normal in 
pseudomigraine 
Hemiplegic Aura MELAS , SMART syndrome Cavernous malformation and capillary 
telangiectasia, gyral thickening
in SMART
Laterality of Visual Aura Fixed Occipital AVM Cranial Bruit, Flow Voids on MR
Migraine coma CADASIL As Above
Odd accompaniments: Carotid Dissection Abnormal  carotid MRA , axial T1 Fat
Pulsatile tinnitus, Horners suppressed image showing  
“flap” of dissection
TIA History Patent Foramen Ovale, CADASIL Crochetage Pattern on EKG,
cardiac murmur
Valsalva Induced TIA Patent Foramen Ovale Crochetage Pattern on EKG, cardiac 
murmur
History of Cranial Irradiation, SMART syndrome Cavernous malformation and capillary
Posterior Fossa telangiectasia interictally, Ictal gyral
thickening in SMART, EEG slowing 
Valproate Induced Rhabdomyolysis CPT II deficiency Family History of death in anesthetic 
accident., decrease serum carnitine or 
muscle 
TABLE 2 Clues to the diagnosis of symptomatic migraine
Intervention should probably be reserved for those with
stroke and in the setting of a randomized clinical trial.
ii. Atrial Myxoma
Left atrial myxoma may present with migraine-like
episodes.106 The migraine usually lasts for one to two
days and are preceded by visual disturbances including
scinitillating scotomas.107 The pathogenesis of migraine
with aura in patients with atrial myxoma may be due to
vasoactive intestinal peptide (VIP) secreted by the
myxoma, or because of microembolization.107 VIP may
induce migraine via its excitatory affect on cerebral or
tr igeminal nucleus caudalis neurons, through the
enhancement of cort ical  g lutaminergic
neurotransmission, or vasodilation of cortical vessels.107
8.  Metabolic Disorders
i. MELAS (Mitochondrial Encephalopathy, Lactic 
Acidosis and Stroke-like episodes)
Altered mitochondrial DNA has been proposed in the
pathogenesis of migraine due to frequent maternal
transmission of the disorder.108 Impaired energy
metabolism and mitochondrial function have been noted
in patients with migraine,109,110 and these defects may
contribute to the pathophysiology of the migraine.112
MELAS is a mitochondrial disorder with a wide range of
symptoms ranging from seizures, headaches, stroke-like
episodes, memory impairment, hemianopsia, hearing
loss, diffuse limb weakness, exercise intolerance, nausea
and vomiting.113 Age of onset may range from 2 to 40
years.113
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Migraine with aura Migraine without aura Not specified
1 Vascular Disorders Contralateral pontine CADASIL (less common) Stroke
cavernosa
CADASIL Cerebrovascular amyloidosis PFO
Plasma hypercoagubility iAVM (less common) Intracranial aneurysm
HERNS Spontaneous cervical artery 
dissection 
iAVM ICAD/VAD
Moyamoya disease
2 Nonvascular Neoplasm (SHM) Pineal Cyst Septum pellucidum cyst
intracranial disorders
Pineal Cyst (less common) Lymphocytic pleocytosis
Hydrocephalus
Ischemia (stroke or TIA) Schimke immuno-osseos 
dysplasia
Meningioma 
3 Infection Neurosyphilis
4 Metabolic Glutathione S- Glutathione S- Horners - HC
transferase M1 transferase M1 Ketotic hypoglycemia
phenotype (less common) phenotype Progressive facial 
hemiatrophy- HM
Carnitine palmityl 
transferase II deficiency
Leigh disease-subacute 
necrotizing encephalopathy
TABLE 3 Causes of symptomatic migraine
One of the more common manifestations of MELAS is
migraine, which is often cyclical, severe, and associated
with vomiting. The migraine may or may not be preceded
by aura, and may be accompanied with complex partial
occipital lobe epilepsy.114 EEG during a migraine episode
may show focal high-voltage delta waves with polyspikes
(FHDPS).115
ii. Carnitine Palmityl Transferase II Deficiency
Carnit ine is used by mitochondria for fatty acid
transportation. In a recent report the diagnosis of
migraine was made according to the International
Headache Society (IHS) criteria for migraine, for two
adolescent girls who had a history of recurrent fatigue,
muscle cramps, and multiple side effects from their
prophylactic treatment. Carnitine levels were measured
and found to be low. Carnitine supplementation was
initiated. Both patients had a reduction in headache
frequency, as well as an improvement in their associated
symptoms and other complaints. A skin and muscle
biopsy obtained from one patient revealed a partial
carnitine palmityl transferase II deficiency in the muscle
only.116 Since valproic acid can induce rhabdomyolysis in
patients,117 and carnitine supplementation would
alleviate migraines, CPT II deficiency must be suspected
in those with exercise intolerance or intolerance to
migraine medication. 
iii.      Ketotic Hypoglycemia
Idiopathic ketotic hypoglycemia is an important cause of
hypoglycemia in children between 1 and 5 years of
age.134 The signs and symptoms of hypoglycemia are
commonly missed as children may present with migraines
triggered by the disorder. Urinary ketones and glucose
levels should be monitored  in such cases. If left
untreated the disease may lead to severe neurological
sequelae and intravenous administration of glucose is
mandatory as it reverses symptoms.118
iv.      Glutathione S-Transferase 
Migraine has been proposed as a polygenic and
multifactorial disorder, and the Glutathione S transferase
(GST) MI gene polymorphism may present in, and is a risk
factor for migraine without aura.119
CONCLUSION 
Migraine is a common headache syndrome. A careful
history and physical examination with testing to exclude
“symptomatic” causes should be considered in those with
atypical presentat ions. Awareness and targeted
questioning will lead to the correct diagnosis. Table 2
summarizes the clues to diagnosis of symptomatic
migraine, and table 3 revisits the causes of symptomatic
migraine.
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